Related Experiment Video
Updated: Jan 28, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Population-based study of congenital heart disease and revisits after pediatric tonsillectomy
Rebecca Miller1, Dmitry Tumin1,2, Christopher McKee1,3
1Department of Anesthesiology and Pain Medicine Nationwide Children's Hospital Columbus Ohio.
Insights
Congenital heart disease (CHD) did not increase the risk of revisits after pediatric tonsillectomy and adenoidectomy (T/A). Other factors like non-cardiac comorbidities are more predictive of post-T/A revisits.
Area of Science:
- Pediatric Surgery
- Cardiology
- Health Services Research
Background:
- Risk stratification is crucial for pediatric surgery, especially elective procedures like tonsillectomy and adenoidectomy (T/A).
- Congenital heart disease (CHD) is a potential risk factor that requires careful consideration in surgical risk assessment.
- T/A procedures, while common, can be associated with a notable rate of adverse events and revisits.
Purpose of the Study:
- To investigate the association between congenital heart disease (CHD) and the risk of 30-day revisits following T/A in children.
- To determine if the severity of CHD influences the likelihood of readmission or emergency department visits after T/A.
- To identify key predictors of revisits in pediatric patients undergoing T/A.
Main Methods:
- Utilized State Inpatient Databases and State Ambulatory Surgery and Services Databases from five US states (2010-2014).
- Identified a cohort of pediatric patients who underwent T/A.
- Employed multivariable logistic regression to assess the association between CHD severity and 30-day revisits, controlling for other factors.
Main Results:
- The study included 244,598 patients, with 858 having minor or major CHD.
- Congenital heart disease (CHD) was not significantly associated with an increased risk of 30-day revisits after T/A (minor CHD OR=1.1, P=.65; major CHD OR=1.2, P=.34).
- Other comorbidities, including chromosomal anomalies, congenital airway anomalies, and neuromuscular impairment, were associated with a higher likelihood of revisits.
Conclusions:
- Neither minor nor major CHD independently predicts an increased risk of 30-day revisits in children undergoing T/A.
- Non-cardiac comorbidities, socioeconomic status, and geographic region may be more valuable for predicting revisit risk after pediatric T/A.
- Current risk stratification for T/A may benefit from incorporating a broader range of patient characteristics beyond cardiac conditions.
Objective:
Accurate assessment of risk factors such as congenital heart disease (CHD) can aid in risk stratification of children presenting for surgery. Risk stratification is especially important in tonsillectomy ± adenoidectomy (T/A), a common pediatric procedure that is usually performed electively, but that has a high rate of adverse events. In this study, we examined the association of CHD with revisits after T/A.
Methods:
We identified children who underwent T/A at hospitals and hospital-owned facilities during 2010 to 2014 using the State Inpatient Databases and State Ambulatory Surgery and Services Databases of Florida, Georgia, Iowa, New York, and Utah. We evaluated the association between CHD severity and the occurrence of an unplanned hospital readmission or ED visit within 30 days following discharge using multivariable logistic regression.
Results:
The analysis included 244,598 patients, of whom 858 had minor or major CHD. In multivariable analysis, CHD was not associated with an increased risk of 30-day revisits (minor OR = 1.1; 95% CI: 0.8, 1.5; P = .65; major OR = 1.2; 95% CI: 0.9, 1.6; P = .34). Other comorbidities, including chromosomal anomalies (OR = 1.4; 95% CI: 1.2, 1.6; P < .001), congenital airway anomalies (OR = 1.3; 95% CI: 1.03, 1.7; P = .03), and neuromuscular impairment (OR = 1.4; 95% CI: 1.2, 1.7; P < .001) predicted an increased likelihood of revisits.
Conclusion:
Neither minor nor major CHD was independently associated with an increased risk of 30-day revisits among children undergoing T/A. Other characteristics, particularly non-cardiac comorbidities, socioeconomic status, and geographic region may be of greater utility for predicting revisit risk following pediatric T/A.
Level Of Evidence:
2b.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
04:55Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Conservation of Small Populations
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Rheumatic Heart Disease I: Introduction
What is Population Genetics?
Population Growth